Who are Diesse's investors?

Diesse's investors include ARCHIMED Japan.

Diesse

Founded 1980 · 203 employees on LinkedIn · 1 known investors

Find your way into Diesse

Paths you didn't know you had: your email and LinkedIn already hold routes to the Diesse team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Diesse develops and manufactures in-vitro diagnostic instruments and reagents for clinical laboratories, including automated ESR (erythrocyte sedimentation rate) analyzers, automated and manual immunoassay systems, and rapid diagnostic tests. Its product lines include VES-MATIC, CHORUS, AUTO-DAT, Enzywell, and iRapid.

Biotech Healthtech Medical Devices

Investors · 1

ARCHIMED Japanlisted by ARCHIMED JapanLyon · $10.8M – $1.1B

Frequently asked questions

What does Diesse do?: Diesse develops and manufactures in-vitro diagnostic instruments and reagents for clinical laboratories, including automated ESR (erythrocyte sedimentation rate) analyzers, automated and manual immunoassay systems, and rapid diagnostic tests. Its product lines include VES-MATIC, CHORUS, AUTO-DAT, Enzywell, and iRapid.
Who are Diesse's investors?: Diesse's investors include ARCHIMED Japan.